[go: up one dir, main page]

ATE144780T1 - Megakaryocytopoietischer faktor - Google Patents

Megakaryocytopoietischer faktor

Info

Publication number
ATE144780T1
ATE144780T1 AT90913091T AT90913091T ATE144780T1 AT E144780 T1 ATE144780 T1 AT E144780T1 AT 90913091 T AT90913091 T AT 90913091T AT 90913091 T AT90913091 T AT 90913091T AT E144780 T1 ATE144780 T1 AT E144780T1
Authority
AT
Austria
Prior art keywords
megakaryocytopoietic
factor
megakaryocytes
colonies
stimulating
Prior art date
Application number
AT90913091T
Other languages
English (en)
Inventor
Thomas G Gesner
Steven C Clark
Katherine Turner
Rodney M Hewick
Original Assignee
Genetics Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/546,114 external-priority patent/US5326558A/en
Application filed by Genetics Inst filed Critical Genetics Inst
Application granted granted Critical
Publication of ATE144780T1 publication Critical patent/ATE144780T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT90913091T 1989-08-08 1990-08-07 Megakaryocytopoietischer faktor ATE144780T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39090189A 1989-08-08 1989-08-08
US45719689A 1989-12-28 1989-12-28
US07/546,114 US5326558A (en) 1989-08-08 1990-06-29 Megakaryocytopoietic factor

Publications (1)

Publication Number Publication Date
ATE144780T1 true ATE144780T1 (de) 1996-11-15

Family

ID=27409968

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90913091T ATE144780T1 (de) 1989-08-08 1990-08-07 Megakaryocytopoietischer faktor

Country Status (9)

Country Link
EP (2) EP0487613B1 (de)
AT (1) ATE144780T1 (de)
AU (1) AU640686B2 (de)
CA (1) CA2064738A1 (de)
DE (1) DE69029040T2 (de)
DK (2) DK0487613T3 (de)
ES (1) ES2094757T3 (de)
HU (1) HUT63441A (de)
WO (1) WO1991002001A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2050584A1 (en) * 1989-04-03 1990-10-04 Barbara W. Grant Megakaryocyte growth promoting activity
US6433142B1 (en) * 1989-08-08 2002-08-13 Genetics Institute, Llc Megakaryocyte stimulating factors
JPH06502621A (ja) * 1990-07-02 1994-03-24 ヒップル　キャンサー　リサーチ　センター ヒトｍｅｇ―ｃｓｆタンパク質と方法
EP0591420A1 (de) * 1991-06-28 1994-04-13 New England Deaconess Hospital Eine differenzierte megakaryozyten-zellinie, die neue megakaryozyten-differenzierungsfaktoren produziert
FI960136A7 (fi) * 1994-03-31 1996-03-11 Amgen Inc Koostumuksia ja menetelmiä megakaryosyyttisen kasvun ja erikoistumisen stimuloimiseksi
US5795569A (en) * 1994-03-31 1998-08-18 Amgen Inc. Mono-pegylated proteins that stimulate megakaryocyte growth and differentiation
US5786335A (en) * 1995-11-06 1998-07-28 Warner-Lambert Company Sulfhydryl containing peptides for treating vascular disease

Also Published As

Publication number Publication date
DE69029040T2 (de) 1997-02-27
DE69029040D1 (de) 1996-12-05
AU640686B2 (en) 1993-09-02
DK0487613T3 (da) 1996-11-25
ES2094757T3 (es) 1997-02-01
EP0487613B1 (de) 1996-10-30
DK15492A (da) 1992-02-07
AU6295790A (en) 1991-03-11
EP0732401A3 (de) 1997-05-14
HU9200385D0 (en) 1992-06-29
WO1991002001A1 (en) 1991-02-21
CA2064738A1 (en) 1991-02-09
HUT63441A (en) 1993-08-30
DK15492D0 (da) 1992-02-07
EP0732401A2 (de) 1996-09-18
EP0487613A1 (de) 1992-06-03

Similar Documents

Publication Publication Date Title
AU549481B2 (en) Hair growing agent
DE3683266D1 (de) Antibiotikum a 40926 mannosyl aglycon.
DE3682767D1 (de) Antibiotika-a40926-n-acylaminoglycuronyl-aglykone und antibiotika-a40926-aglykone.
DK312688A (da) Glykkopeptid-antibiotika
DE69029040D1 (de) Megakaryocytopoietischer faktor
DK0406745T3 (da) Antibiotiske GE 2270 faktorer A1, A2, A3 og H
BG50159A3 (bg) Метод за получаване на производни на пиранобензоксадиазол
ES2108680T3 (es) Uso del derivado n-n-butilo de desoxinojirimicina en la fabricacion de un medicamento.
DK0529410T3 (da) Antibiotikum GE 2270 faktor C2a
ATE111487T1 (de) Antibiotisches zyklisches hexapeptid.
EP0454429A3 (en) Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases
GR3004095T3 (de)
DE69014196D1 (de) 3,6-diamino-2,5-pyrazindicarbonitril und ihre herstellung.
AU1494395A (en) The use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
FR2652086B1 (fr) Compose nouveau d'origine vegetale, derive de l'acide cafeique, l'oraposide; composition a usage therapeutique et composition dermato-cosmetique le contenant.
ES2039255T3 (es) Utilizacion de n-((1-etil-2-pirrolidinil)metil)-2-metoxi-5-sulfamoil-benzamida en el tratamiento de la esterilidad.
ES2162992T3 (es) Uso de 3-alfa-hidroxi-5-alfa-androsta-16-eno como medicamento.
KR890002236U (ko) 의료용 가아제의 증살통

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee